WBR0421: Difference between revisions

Jump to navigation Jump to search
Rim Halaby (talk | contribs)
Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Biochemistry |SubCategory=Endocrine |MainCategory=Biochemistry |SubCategory=Endocrine |MainCategory=..."
 
WikiBot (talk | contribs)
m refreshing WBR questions
 
(8 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor= {{YD}} (Reviewed by  {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Vascular
|MainCategory=Biochemistry
|MainCategory=Biochemistry
|SubCategory=Endocrine
|MainCategory=Biochemistry
|Prompt=A 17 year old female patient presents to the emergency department with chest pain and dyspnea at rest. The patient explains he takes atorvastatin for hypercholesterolemia. Her family history is notable for death of myocardial infarction in multiple members of her family at young age. Vital signs show a temperature of 37 degrees C (98.6 degrees F), heart rate of 102 beats per minute, and blood pressure of 110/70 mmHg.  On physical examination, the physician notes tendon xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. Work-up in the emergency department reveals an electrocardiogram (ECG) with ST-segment elevation in the anterior leads, elevation of tropnin I levels, and low density lipoprotein-cholesterol (LDL-C) levels of 980 mg/dL. Which of the following explains the pathogenesis of this patient’s disease?
|SubCategory=Vascular
 
|Prompt=A 38-year-old woman is brought to the emergency department with complaints of chest pain and shortness of breath at rest. She describes her pain as a crushing sensation in the middle of her chest that radiates to her left arm and is associated with nausea and cold sweats. The patient receives daily atorvastatin for hypercholesterolemia. She reports that multiple members of her family died at a young age from cardiovascular disease. On physical examination, the physician notes xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. In the ED, her temperature is 37.0 °C (98.6 °F), heart rate is 112/min, and blood pressure is 148/84 mmHg. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads. Her lab work-up is remarkable for elevation of troponin I and low-density lipoprotein-cholesterol (LDL-C) concentration of 680 mg/dL. The physician suspects that the patient's condition may be caused by an inherited disease. Which of the following explains the pathogenesis of this patient’s inherited disease?
 
|Explanation=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane commonly due to a mutation in ''LDLR'' gene in chromosome 19. The mutation results in abnormally elevated concentration of serum LDL-C due to decreased clearance of LDL-C at the level of the liver, which predisposes affected patients to accelerated [[atherosclerosis]] at a young age with an increased risk of early cardiovascular disease. Patients may present at young age (before the age of 50) with myocardial infarction along with signs of [[hypercholesterolemia]] on physical exam, such as [[Achilles tendon xanthoma]] and [[arcus senilis corneae]], as described in the patient in this vignette.  
|Explanation=Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence of deficiency of LDL receptors on hepatocytes plasma membrane due to a mutation of LDLR gene on chromosome 19. The mutation results in abnormally elevated amounts of serum LDL due to decreased clearance of LDL at the level of the liver; predisposing affected patients to accelerating atherosclerosis at a young age with increased risk of cardiovascular disease, such as myocardial infarction, and signs of hypercholesterolemia on physical exam, such as Achilles tendon xanthoma and arcus senilis corneae, as described in the patient in the vignette.
FH has a homozygous form and a heterozygous form.  The homozygous form is more severe; it occurs in patients who have 2 mutated alleles of the gene.  Classically, patients with homozygous mutation have LDL levels approximately 1000 mg/dL that are often refractory to anti-lipidemic medications with cardiovascular complications that can occur as early as during childhood.  Heterozygous form occurs when 1 mutated allele is inherited.  In the heterozygous form, LDL levels are classically lower than that of homozygous FH, in the range of 300-500 mg/dL.  In heterogeneous FH, symptoms may not occur as early as homogeneous FH but the risk of atherosclerosis is still high when compared to the general population.


|AnswerA=Increased hepatocyte production of LDL  
FH has a homozygous form and a heterozygous form. The homozygous form is more severe; it occurs among patients who have 2 mutated alleles of the ''LDLR'' gene.  Classically, patients with homozygous mutation have LDL-C concentrations greater than 500 mg/dL that are often refractory to anti-lipidemic medications. These patients are also at high risk of early cardiovascular complications that may occur as early as adolescence or young adulthood. Heterozygous form develop when only 1 mutated allele is inherited. In the heterozygous form, LDL-C concentrations are classically lower than that of homozygous forms in the range of 300-500 mg/dL. In heterogeneous FH, cardiovascular disease may not manifest as early as homogeneous FH, but the risk of atherosclerosis is still high when compared with the general population.
|AnswerAExp=Increased hepatocytes production of LDL is not the pathogenesis of FH. LDL production is increased secondary to insulin resistance and diabetes mellitus, renal disease, and in obese individuals.
|AnswerA=Increased hepatocyte production of LDL-C
|AnswerB=LDL-receptor overexpression  
|AnswerAExp=The increased hepatocytes production of LDL-C is not the pathogenesis of FH. LDL production is frequently increased secondary to insulin resistance, [[diabetes mellitus]], renal disease, and in obese individuals.
|AnswerBExp=LDL receptor over-expression occurs with statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase.  In this case, the risk of atherosclerosis is expected to be reduced.
|AnswerB=LDL-receptor overexpression
|AnswerC=Deficiency of high density lipoprotein (HDL)  
|AnswerBExp=LDL receptor over-expression occurs following initiation of statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase.
|AnswerCExp=Deficiency of HDL is a genetic mutation of the ABC1 gene.  It might cause Tangier disease (TD) and some types of hypoalphalipoproteinemia (HA), both of which are characterized by low HDL.  HDL is considered an inverse predictor of atherosclerosis.  However, the patient’s work-up in the vignette showed abnormally elevated serum LDL levels, suggestive of FH.
|AnswerC=Deficiency of high density lipoprotein-cholesterol (HDL-C)
|AnswerCExp=Deficiency of HDL-C frequently results from a genetic mutation in the ''ABC1'' gene and may cause [[Tangier disease]] (TD) and some types of [[hypoalphalipoproteinemia]] (HA). Classically, HDL-C concentration has been inversely associated with [[atherosclerosis]], but more recently, the emphasis of cardiovascular risk reduction shifted from the numerical concentration of HDL-C towards the function of HDL-C and ApoA-I given their capacity of reverse cholesterol transport.
|AnswerD=Deficiency of LDL receptors on hepatocyte plasma membrane
|AnswerD=Deficiency of LDL receptors on hepatocyte plasma membrane
|AnswerDExp=FH is characterized by myocardial infarction at young age.  FH is caused by a mutation of the LDL receptor at the hepatocytes with abnormally elevated levels of circulating LDL.
|AnswerDExp=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane.
|AnswerE=Deficiency of lipoprotein lipoprotein lipase (LPL)
|AnswerE=Deficiency of lipoprotein lipase (LPL)
|AnswerEExp=Deficiency of lipoprotein lipase (LPL) is type I dyslipidemia, called hyperchylomicronemia, which is characterized by elevated levels of circulating chylomicrons causing high levels of triglycerides and cholesterol.  Although eruptive xanthoma can be present in hyperchylomicronemia, a classic complication of hyperchylomicronemia is usually recurrent pancreatitis, not myocardial infarction.
|AnswerEExp=Deficiency of lipoprotein lipase (LPL) is type I dyslipidemia, called hyperchylomicronemia, which is characterized by elevated concentration of circulating chylomicrons that result in high concentration of triglycerides and cholesterol.  Although eruptive xanthoma may be present in hyperchylomicronemia, a classic complication of hyperchylomicronemia is usually recurrent pancreatitis (due to hypertriglyceridemia), not myocardial infarction.
|EducationalObjectives=[[Familial]] [[hypercholesterolemia]] (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of [[LDL]] receptors on the hepatocyte plasma membrane commonly due to a mutation in ''LDLR'' gene in chromosome 19. Homozygous forms of FH may manifest with early atherosclerosis along with signs of hypercholesterolemia.
|References=Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989;9(1 Suppl):I3-7.<br>
First Aid 2014 page 87, 118
|RightAnswer=D
|RightAnswer=D
|WBRKeyword=LDL, familial, hypercholesterolemia, myocardial, infarction
|WBRKeyword=LDL, Familial hypercholesterolemia, Myocardial infarction, Autosomal dominant, FH, Inheritance, Hypercholesterolemia
|Approved=No
|Approved=Yes
}}
}}

Latest revision as of 00:30, 28 October 2020

 
Author [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Biochemistry
Sub Category SubCategory::Vascular
Prompt [[Prompt::A 38-year-old woman is brought to the emergency department with complaints of chest pain and shortness of breath at rest. She describes her pain as a crushing sensation in the middle of her chest that radiates to her left arm and is associated with nausea and cold sweats. The patient receives daily atorvastatin for hypercholesterolemia. She reports that multiple members of her family died at a young age from cardiovascular disease. On physical examination, the physician notes xanthomas on the Achilles tendon and arcus senilis corneae on the outer margin of the iris. In the ED, her temperature is 37.0 °C (98.6 °F), heart rate is 112/min, and blood pressure is 148/84 mmHg. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads. Her lab work-up is remarkable for elevation of troponin I and low-density lipoprotein-cholesterol (LDL-C) concentration of 680 mg/dL. The physician suspects that the patient's condition may be caused by an inherited disease. Which of the following explains the pathogenesis of this patient’s inherited disease?]]
Answer A AnswerA::Increased hepatocyte production of LDL-C
Answer A Explanation [[AnswerAExp::The increased hepatocytes production of LDL-C is not the pathogenesis of FH. LDL production is frequently increased secondary to insulin resistance, diabetes mellitus, renal disease, and in obese individuals.]]
Answer B AnswerB::LDL-receptor overexpression
Answer B Explanation AnswerBExp::LDL receptor over-expression occurs following initiation of statin therapy secondary to decreased production of cholesterol by inhibition of HMG-CoA reductase.
Answer C AnswerC::Deficiency of high density lipoprotein-cholesterol (HDL-C)
Answer C Explanation [[AnswerCExp::Deficiency of HDL-C frequently results from a genetic mutation in the ABC1 gene and may cause Tangier disease (TD) and some types of hypoalphalipoproteinemia (HA). Classically, HDL-C concentration has been inversely associated with atherosclerosis, but more recently, the emphasis of cardiovascular risk reduction shifted from the numerical concentration of HDL-C towards the function of HDL-C and ApoA-I given their capacity of reverse cholesterol transport.]]
Answer D AnswerD::Deficiency of LDL receptors on hepatocyte plasma membrane
Answer D Explanation [[AnswerDExp::Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane.]]
Answer E AnswerE::Deficiency of lipoprotein lipase (LPL)
Answer E Explanation [[AnswerEExp::Deficiency of lipoprotein lipase (LPL) is type I dyslipidemia, called hyperchylomicronemia, which is characterized by elevated concentration of circulating chylomicrons that result in high concentration of triglycerides and cholesterol. Although eruptive xanthoma may be present in hyperchylomicronemia, a classic complication of hyperchylomicronemia is usually recurrent pancreatitis (due to hypertriglyceridemia), not myocardial infarction.]]
Right Answer RightAnswer::D
Explanation [[Explanation::Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane commonly due to a mutation in LDLR gene in chromosome 19. The mutation results in abnormally elevated concentration of serum LDL-C due to decreased clearance of LDL-C at the level of the liver, which predisposes affected patients to accelerated atherosclerosis at a young age with an increased risk of early cardiovascular disease. Patients may present at young age (before the age of 50) with myocardial infarction along with signs of hypercholesterolemia on physical exam, such as Achilles tendon xanthoma and arcus senilis corneae, as described in the patient in this vignette.

FH has a homozygous form and a heterozygous form. The homozygous form is more severe; it occurs among patients who have 2 mutated alleles of the LDLR gene. Classically, patients with homozygous mutation have LDL-C concentrations greater than 500 mg/dL that are often refractory to anti-lipidemic medications. These patients are also at high risk of early cardiovascular complications that may occur as early as adolescence or young adulthood. Heterozygous form develop when only 1 mutated allele is inherited. In the heterozygous form, LDL-C concentrations are classically lower than that of homozygous forms in the range of 300-500 mg/dL. In heterogeneous FH, cardiovascular disease may not manifest as early as homogeneous FH, but the risk of atherosclerosis is still high when compared with the general population.
Educational Objective: Familial hypercholesterolemia (FH) is an autosomal dominant inherited disease characterized by the absence or deficiency of LDL receptors on the hepatocyte plasma membrane commonly due to a mutation in LDLR gene in chromosome 19. Homozygous forms of FH may manifest with early atherosclerosis along with signs of hypercholesterolemia.
References: Motulsky AG. Genetic aspects of familial hypercholesterolemia and its diagnosis. Arteriosclerosis. 1989;9(1 Suppl):I3-7.
First Aid 2014 page 87, 118]]

Approved Approved::Yes
Keyword WBRKeyword::LDL, WBRKeyword::Familial hypercholesterolemia, WBRKeyword::Myocardial infarction, WBRKeyword::Autosomal dominant, WBRKeyword::FH, WBRKeyword::Inheritance, WBRKeyword::Hypercholesterolemia
Linked Question Linked::
Order in Linked Questions LinkedOrder::